NM_000123.4(ERCC5):c.2878G>T (p.Glu960Ter)Pathogenic
Xeroderma pigmentosum, group G|Xeroderma pigmentosum|not provided
β
β
ββ2026β Residue 960
NM_000123.4(ERCC5):c.2413G>A (p.Gly805Arg)Pathogenic
not provided|Xeroderma pigmentosum
β
β
ββ2026β Residue 805
NM_000123.4(ERCC5):c.205C>T (p.Arg69Ter)Pathogenic
Xeroderma pigmentosum, group G|not provided|Xeroderma pigmentosum
β
β
ββ2025β Residue 69
NM_000123.4(ERCC5):c.1753G>T (p.Glu585Ter)Pathogenic
not provided
β
β
ββ2025β Residue 585
NM_000123.4(ERCC5):c.2705dup (p.Asn902fs)Pathogenic
See cases|Cerebrooculofacioskeletal syndrome 3
β
β
ββ2025β Residue 902
NM_000123.4(ERCC5):c.2375C>T (p.Ala792Val)Likely pathogenic
Xeroderma pigmentosum, group G|Xeroderma pigmentosum, group G;Cerebrooculofacioskeletal syndrome 3|Xeroderma pigmentosum
β
β
ββ2025β Residue 792
NM_000123.4(ERCC5):c.2836G>T (p.Gly946Ter)Pathogenic
Cerebrooculofacioskeletal syndrome 3;Xeroderma pigmentosum, group G|not provided
β
β
ββ2025β Residue 946
NM_000123.4(ERCC5):c.1115_1118del (p.Arg372fs)Pathogenic
Xeroderma pigmentosum, group G|not provided|Xeroderma pigmentosum, group G;Cerebrooculofacioskeletal syndrome 3
β
β
ββ2024β Residue 372
NM_000123.4(ERCC5):c.1173dup (p.Lys392Ter)Pathogenic
Xeroderma pigmentosum|Xeroderma pigmentosum, group G;Cerebrooculofacioskeletal syndrome 3
β
β
ββ2024β Residue 392
NM_000123.4(ERCC5):c.2751del (p.Lys917fs)Pathogenic
Xeroderma pigmentosum, group G|Xeroderma pigmentosum|not provided|Xeroderma pigmentosum, group G;Cerebrooculofacioskeletal syndrome 3
β
β
ββ2024β Residue 917
NM_000123.4(ERCC5):c.2453C>T (p.Ala818Val)Pathogenic
Xeroderma pigmentosum|not provided
β
β
ββ2023β Residue 818
NM_000123.4(ERCC5):c.2606_2607del (p.Val869fs)Pathogenic
Xeroderma pigmentosum|not provided
β
β
ββ2022β Residue 869
NM_000123.4(ERCC5):c.673-2A>GPathogenic
not provided|Cerebrooculofacioskeletal syndrome 3;Xeroderma pigmentosum, group G
β
β
ββ2021
NM_000123.4(ERCC5):c.996_997del (p.Lys333fs)Pathogenic
not provided
β
βββ2026β Residue 333
NM_000123.4(ERCC5):c.2784dup (p.Asn929Ter)Pathogenic
not provided
β
βββ2026β Residue 929
NM_000123.4(ERCC5):c.2200-2A>TLikely pathogenic
not provided
β
βββ2026
NM_000123.4(ERCC5):c.2518_2521del (p.Phe840fs)Pathogenic
not provided
β
βββ2025β Residue 840
NM_000123.4(ERCC5):c.2713del (p.Lys904_Ile905insTer)Pathogenic
not provided
β
βββ2025β Residue 904
NM_000123.4(ERCC5):c.2698C>T (p.Gln900Ter)Pathogenic
not provided
β
βββ2025β Residue 900
NM_000123.4(ERCC5):c.2739del (p.Lys913_Val914insTer)Pathogenic
Cerebrooculofacioskeletal syndrome 3
β
βββ2025β Residue 913